Health

Corporate investors are increasingly building a presence in India as the country's roster of globally-focused startups grows.

As India's startup ecosystem takes off, women are becoming more prominent as both founders and investors.

Cancer survival rates have increased dramatically over the past century, but immunotherapies are not a holy grail — yet.

Cheaper and more powerful lidar and technologies that can augment it are getting investor attention.

Souring trade relations between the US and China are forcing global corporations to shift their investment focus.

Seed-stage investor High-Tech Gründerfonds secured backing from a range of German corporates for its fourth fund, taking its total capital under management past €1.3bn.

Managing partner Vijay Patel tells us why CVS Health Ventures has launched a growth fund as its parent makes a big primary care play.

A cure for diabetes, food made from CO2 and a wound dressing that kills superbugs are all a step closer to reality thanks to these 10 spinouts.

CVC veteran Eric Steager has left Touchdown Ventures and joined Purdue University subsidiary Purdue Ventures as managing director.

From excessive dilution to aggressive clauses, corporate investors look for these red flags when scouting new investments.

GV helped head up a 35-strong investor network backing Curie, which has raised $520m to bring CVC-like strategic help to its seed-stage drug developer portfolio.